{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:02:21Z","timestamp":1793106141159,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T00:00:00Z","timestamp":1498435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Industrial Research Fund of the University of Antwerp","award":["32387"],"award-info":[{"award-number":["32387"]}]},{"name":"Research Foundation \u2212 Flanders (FWO)","award":["1120816N"],"award-info":[{"award-number":["1120816N"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejogrb.2017.06.036","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T02:15:48Z","timestamp":1498529748000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["First-void urine: A potential biomarker source for triage of high-risk human papillomavirus infected women"],"prefix":"10.1016","volume":"216","author":[{"given":"Severien","family":"Van Keer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Pattyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebren A.A.","family":"Tjalma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xaveer","family":"Van Ostade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Ieven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Vorsters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2017.06.036_bib0005","unstructured":"GLOBOCAN. Cervical Cancer: Estimated Incidence, Mortality and Prevalence Worldwidein 2012 [Available from: http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx.]"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.036_bib0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"11","key":"10.1016\/j.ejogrb.2017.06.036_bib0015","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.ejogrb.2017.06.036_bib0020","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.vaccine.2006.05.031","article-title":"Chapter 6: epidemiology and transmission dynamics of genital HPV infection","volume":"24","author":"Burchell","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ejogrb.2017.06.036_bib0025","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"Group A: a 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.ejogrb.2017.06.036_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.virol.2013.04.023","article-title":"Cross-roads in the classification of papillomaviruses","volume":"445","author":"de Villiers","year":"2013","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.ejogrb.2017.06.036_bib0035","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.cmi.2015.05.011","article-title":"Molecular methods for identification and characterization of novel papillomaviruses","volume":"21","author":"Kocjan","year":"2015","journal-title":"Clin Microbiol Infec"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0040","unstructured":"IARC. Agents classified by the IARC Monographs. 2016."},{"issue":"9916","key":"10.1016\/j.ejogrb.2017.06.036_bib0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ejogrb.2017.06.036_bib0050","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","article-title":"European guidelines for quality assurance in cervical cancer screening: summary of the supplements on HPV screening and vaccination","volume":"1","author":"von Karsa","year":"2015","journal-title":"Papillomavirus Res"},{"issue":"Suppl. 5","key":"10.1016\/j.ejogrb.2017.06.036_bib0060","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ejogrb.2017.06.036_bib0065","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1200\/JCO.2014.59.0331","article-title":"There are two prophylactic human papillomavirus vaccines against cancer, and they are different","volume":"33","author":"Tjalma","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.06.036_bib0070","doi-asserted-by":"crossref","first-page":"E255","DOI":"10.3747\/co.21.1720","article-title":"The road ahead for cervical cancer prevention and control","volume":"21","author":"Tota","year":"2014","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.06.036_bib0075","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jmv.24085","article-title":"Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening","volume":"87","author":"Burroni","year":"2015","journal-title":"J Med Virol"},{"issue":"9","key":"10.1016\/j.ejogrb.2017.06.036_bib0080","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1158\/1940-6207.CAPR-16-0038","article-title":"Comparison between urine and cervical samples for HPV DNA detection and typing in young women in Colombia","volume":"9","author":"Combita","year":"2016","journal-title":"Cancer Prevent Res (Philadelphia, Pa)"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.06.036_bib0085","first-page":"299","article-title":"Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions","volume":"290","author":"Ducancelle","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.06.036_bib0090","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ijc.30092","article-title":"Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda","volume":"139","author":"Franceschi","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0095","doi-asserted-by":"crossref","first-page":"g5264","DOI":"10.1136\/bmj.g5264","article-title":"Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis","volume":"349","author":"Pathak","year":"2014","journal-title":"Bmj"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.06.036_bib0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050750","article-title":"Long-term follow-up of HPV infection using urine and cervical quantitative HPV DNA testing","volume":"17","author":"Vorsters","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/CLEP.S39799","article-title":"Monitoring human papillomavirus prevalence in urine samples: a review","volume":"5","author":"Enerly","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0110","unstructured":"Smith JS, Smith JB, Faherty BR, Isaacson SC, Des Marais AC, Fakner A, et al., editors. Effect of urine preservative on HPV testing results among urine samples. HPV2017; 2017; Cape-Town, South-Africa."},{"issue":"3","key":"10.1016\/j.ejogrb.2017.06.036_bib0115","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/JCM.02022-06","article-title":"Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems","volume":"45","author":"Payan","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.036_bib0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/JCM.01623-13","article-title":"Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic","volume":"52","author":"Sahasrabuddhe","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.ejogrb.2017.06.036_bib0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jiac.2016.05.009","article-title":"Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus","volume":"22","author":"Hagihara","year":"2016","journal-title":"J Infect Chemother"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.06.036_bib0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10096-011-1358-z","article-title":"Detection of human papillomavirus DNA in urine: a review of the literature","volume":"31","author":"Vorsters","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.06.036_bib0135","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9378(43)90439-9","article-title":"The use of endocervical and endometrial smears in the diagnosis of cancer and of other conditions of the uterus","volume":"46","author":"Papanicolaou","year":"1943","journal-title":"Am J Obst Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0140","doi-asserted-by":"crossref","first-page":"g6252","DOI":"10.1136\/bmj.g6252","article-title":"Urine testing for HPV: rationale for using first void","volume":"349","author":"Vorsters","year":"2014","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.06.036_bib0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis","volume":"15","author":"Arbyn","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejogrb.2017.06.036_bib0150","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/bjc.2016.290","article-title":"Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study","volume":"115","author":"Landy","year":"2016","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.06.036_bib0155","doi-asserted-by":"crossref","first-page":"e010660","DOI":"10.1136\/bmjopen-2015-010660","article-title":"Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study)","volume":"6","author":"Stanczuk","year":"2016","journal-title":"Bmj Open"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0160","first-page":"Cd002834","article-title":"Interventions targeted at women to encourage the uptake of cervical screening","volume":"5","author":"Everett","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.06.036_bib0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1258\/jms.2009.009073","article-title":"Barriers to cervical cancer screening attendance in England: a population-based survey","volume":"16","author":"Waller","year":"2009","journal-title":"J Med Screen"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0170","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1186\/s12889-016-3474-2","article-title":"HPV testing: a mixed-method approach to understand why women prefer self-collection in a middle-income country","volume":"16","author":"Arrossi","year":"2016","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.036_bib0175","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.1111\/1469-0691.12063","article-title":"Vaginal self-sampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening","volume":"19","author":"Tamalet","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.06.036_bib0180","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1007\/BF03405681","article-title":"Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis","volume":"104","author":"Racey","year":"2013","journal-title":"Canad J Publ Health"},{"issue":"16","key":"10.1016\/j.ejogrb.2017.06.036_bib0185","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.ejca.2015.07.006","article-title":"Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials","volume":"51","author":"Verdoodt","year":"2015","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.06.036_bib0190","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jinf.2015.05.001","article-title":"Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinics","volume":"71","author":"Ducancelle","year":"2015","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.06.036_bib0195","first-page":"513","article-title":"Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions","volume":"163","author":"Sellors","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcv.2015.11.005","article-title":"Comparison of urine specimen collection times and testing fractions for the detection of high-risk human papillomavirus and high-grade cervical precancer","volume":"74","author":"Senkomago","year":"2016","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.036_bib0205","first-page":"4","article-title":"Role of human papilloma virus testing in cervical cancer prevention","volume":"49","author":"Fey","year":"2004","journal-title":"J Midwif Women's Health"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.06.036_bib0210","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2017.06.036_bib0215","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0220","unstructured":"FDA. Biomarker Qualification Program 2016 [updated 20\/09\/2016. Available from: http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DrugDevelopmentToolsQualificationProgram\/ucm284076.htm."},{"issue":"14","key":"10.1016\/j.ejogrb.2017.06.036_bib0225","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.ejogrb.2017.06.036_bib0230","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/ijc.24774","article-title":"How to evaluate emerging technologies in cervical cancer screening?","volume":"125","author":"Arbyn","year":"2009","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.06.036_bib0235","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.036_bib0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1055-9965.EPI-13-0173","article-title":"Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy","volume":"23","author":"Dijkstra","year":"2014","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.06.036_bib0245","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/bjc.2011.581","article-title":"HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications","volume":"106","author":"Rijkaart","year":"2012","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.06.036_bib0250","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1586\/14737159.2015.1012068","article-title":"Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkers","volume":"15","author":"Koeneman","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0255","first-page":"1","article-title":"Triage of high-risk HPV positive women in cervical cancer screening","author":"Ebisch","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"issue":"9","key":"10.1016\/j.ejogrb.2017.06.036_bib0260","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737159.2016.1217157","article-title":"Management of high-risk HPV-positive women for detection of cervical (pre)cancer","volume":"16","author":"Luttmer","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.036_bib0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1559-0275-10-13","article-title":"Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges","volume":"10","author":"Fuzery","year":"2013","journal-title":"Clinical Proteom"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.06.036_bib0270","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/LGT.0000000000000231","article-title":"Biomarkers for cervical cancer prevention programs: the long and winding road from discovery to clinical use","volume":"20","author":"Wentzensen","year":"2016","journal-title":"J Low Genit Tract Dis"},{"issue":"11","key":"10.1016\/j.ejogrb.2017.06.036_bib0275","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1158\/1055-9965.EPI-09-0025","article-title":"Human papillomavirus 16 load and E2\/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?","volume":"18","author":"Boulet","year":"2009","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"8","key":"10.1016\/j.ejogrb.2017.06.036_bib0280","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/cam4.473","article-title":"Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections","volume":"4","author":"Depuydt","year":"2015","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.ejogrb.2017.06.036_bib0285","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s10096-014-2147-2","article-title":"Optimization of HPV DNA detection in urine by improving collection, storage, and extraction","volume":"33","author":"Vorsters","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.06.036_bib0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3835(03)00014-4","article-title":"Altered urinary profiles of polyamines and endogenous steroids in patients with benign cervical disease and cervical cancer","volume":"201","author":"Lee","year":"2003","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.036_bib0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084710","article-title":"Detection of cervical cancer biomarker patterns in blood plasma and urine by differential scanning calorimetry and mass spectrometry","volume":"9","author":"Garbett","year":"2014","journal-title":"Plos One"},{"issue":"October","key":"10.1016\/j.ejogrb.2017.06.036_bib0300","first-page":"170","article-title":"Detection of DNA methylation markers in urine of cervical cancer patients: a feasibility study","author":"Rurup","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ejogrb.2017.06.036_bib0305","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1158\/1055-9965.EPI-06-0694","article-title":"Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia","volume":"16","author":"Feng","year":"2007","journal-title":"Cancer Epidem Biomar"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0310","first-page":"2016","article-title":"Molecular triage of premalignant lesions in liquid-based cervical cytology and circulating cell free DNA from urine, using methylated viral and host genes","author":"Guerrero-Preston","year":"2016","journal-title":"Cancer Prevent Res (Philadelphia Pa)"},{"issue":"7","key":"10.1016\/j.ejogrb.2017.06.036_bib0315","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.036_bib0320","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejca.2013.08.022","article-title":"Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract \u2212 a systematic review and meta-analysis","volume":"50","author":"Thomas","year":"2014","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.06.036_bib0325","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/cyt.12150","article-title":"Genotyping of high-risk human papillomaviruses in p16\/Ki-67-positive urothelial carcinoma cells: even a worm will turn","volume":"26","author":"Advenier","year":"2015","journal-title":"Cytopathology"},{"issue":"10","key":"10.1016\/j.ejogrb.2017.06.036_bib0330","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/cncy.21462","article-title":"p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-Grade urothelial cancer cells","volume":"122","author":"Piaton","year":"2014","journal-title":"Cancer Cytopathol"},{"issue":"9","key":"10.1016\/j.ejogrb.2017.06.036_bib0335","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1464-410X.2007.07224.x","article-title":"Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison","volume":"101","author":"van der Aa","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0340","first-page":"2017","article-title":"HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable to a physician-taken smear or brush-based self-sample: cross-sectional data from a triage population","author":"Leeman","year":"2016","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.036_bib0345","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12985-017-0744-2","article-title":"Evaluation of the performance of Human Papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan","volume":"14","author":"Tshomo","year":"2017","journal-title":"Virol J"},{"issue":"8","key":"10.1016\/j.ejogrb.2017.06.036_bib0350","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1128\/JCM.00618-16","article-title":"Comparison of two widely used human papillomavirus detection and genotyping methods, GP5+\/6+-Based PCR followed by reverse line blot hybridization and multiplex type-Specific E7-Based PCR","volume":"54","author":"Clifford","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0355","unstructured":"Pattyn J, Dekoeijer M, Van Keer S, Biesmans S, Ieven M, Beyers K, et al. editors. HPV DNA detection in urine: effect of a first-void urine collection device and timing of collection. HPV2017. 2017. Cape-Town, South-Africa."},{"issue":"2","key":"10.1016\/j.ejogrb.2017.06.036_bib0360","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ygyno.2016.02.012","article-title":"Validation of the FAM19A4\/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women","volume":"141","author":"De Strooper","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.06.036_bib0365","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/14737159.2014.897610","article-title":"Cancer diagnostic classifiers based on quantitative DNA methylation","volume":"14","author":"Lorincz","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"issue":"12","key":"10.1016\/j.ejogrb.2017.06.036_bib0370","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1158\/1055-9965.EPI-12-0905","article-title":"Human papillomavirus DNA methylation as a potential biomarker for cervical cancer","volume":"21","author":"Clarke","year":"2012","journal-title":"Cancer Epidem Biomar"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0375","first-page":"2012","article-title":"Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape","author":"Snellenberg","year":"2012","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.036_bib0380","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2009.07.041","article-title":"Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples","volume":"58","author":"Renard","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0385","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1186\/s12885-016-2748-5","article-title":"Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive\/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer","volume":"16","author":"Roperch","year":"2016","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.06.036_bib0390","doi-asserted-by":"crossref","first-page":"e94023","DOI":"10.1371\/journal.pone.0094023","article-title":"Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer","volume":"9","author":"Andersson","year":"2014","journal-title":"Plos One"},{"issue":"7","key":"10.1016\/j.ejogrb.2017.06.036_bib0395","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01443610903061736","article-title":"Urine HPV-DNA detection for cervical cancer screening: prospects and prejudices","volume":"29","author":"Sehgal","year":"2009","journal-title":"J Obstet Gynaecol"},{"issue":"10","key":"10.1016\/j.ejogrb.2017.06.036_bib0400","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1055-9965.EPI-08-0306","article-title":"Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia","volume":"17","author":"Cuschieri","year":"2008","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"3a","key":"10.1016\/j.ejogrb.2017.06.036_bib0405","first-page":"1257","article-title":"Extracellular nucleic acids and their potential as diagnostic, prognostic and predictive biomarkers","volume":"27","author":"O'Driscoll","year":"2007","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.06.036_bib0410","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2217\/bmm.13.44","article-title":"Stability of miRNA in human urine supports its biomarker potential","volume":"7","author":"Mall","year":"2013","journal-title":"Biomark Med"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.06.036_bib0415","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrurol.2009.40","article-title":"The use of PCA3 in the diagnosis of prostate cancer","volume":"6","author":"Hessels","year":"2009","journal-title":"Nat Rev Urol"},{"issue":"25","key":"10.1016\/j.ejogrb.2017.06.036_bib0420","doi-asserted-by":"crossref","first-page":"38731","DOI":"10.18632\/oncotarget.9587","article-title":"Urinary mRNA biomarker panel for the detection of urothelial carcinoma","volume":"7","author":"Urquidi","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.06.036_bib0425","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/ajt.14082","article-title":"Urinary microRNA as biomarker in renal transplantation","volume":"17","author":"van de Vrie","year":"2016","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ejogrb.2017.06.036_bib0430","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s11255-016-1406-9","article-title":"Advantage of urine based molecular diagnosis of Zika virus","volume":"48","author":"Lamb","year":"2016","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"10.1016\/j.ejogrb.2017.06.036_bib0435","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/10408363.2016.1190682","article-title":"Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction","volume":"53","author":"Foster","year":"2016","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0440","doi-asserted-by":"crossref","first-page":"782798","DOI":"10.1155\/2015\/782798","article-title":"Human urine proteomics: analytical techniques and clinical applications in renal diseases","volume":"2015","author":"Kalantari","year":"2015","journal-title":"Int J Proteom"},{"issue":"12","key":"10.1016\/j.ejogrb.2017.06.036_bib0445","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/ijc.28616","article-title":"Lower cost strategies for triage of human papillomavirus DNA-positive women","volume":"134","author":"Qiao","year":"2014","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.ejogrb.2017.06.036_bib0450","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1074\/mcp.R800001-MCP200","article-title":"Urine in clinical proteomics","volume":"7","author":"Decramer","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ejogrb.2017.06.036_bib0455","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1477-5956-8-63","article-title":"Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract","volume":"8","author":"Zegels","year":"2010","journal-title":"Proteome Sci"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.06.036_bib0460","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12263-009-0121-x","article-title":"Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomics","volume":"4","author":"Crosley","year":"2009","journal-title":"Genes Nutr"},{"issue":"9","key":"10.1016\/j.ejogrb.2017.06.036_bib0465","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2006-7-9-r80","article-title":"The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins","volume":"7","author":"Adachi","year":"2006","journal-title":"Genome Biol"},{"issue":"6","key":"10.1016\/j.ejogrb.2017.06.036_bib0470","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/pmic.201000566","article-title":"Toward a standardized urine proteome analysis methodology","volume":"11","author":"Court","year":"2011","journal-title":"Proteomics"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.06.036_bib0475","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/1055-9965.EPI-10-0069","article-title":"Urine collection and processing for protein biomarker discovery and quantification","volume":"19","author":"Thomas","year":"2010","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"10","key":"10.1016\/j.ejogrb.2017.06.036_bib0480","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1021\/pr800406r","article-title":"Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers","volume":"7","author":"Burgener","year":"2008","journal-title":"J Proteome Res"},{"issue":"10","key":"10.1016\/j.ejogrb.2017.06.036_bib0485","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1074\/mcp.M110.000992","article-title":"Optimizing a proteomics platform for urine biomarker discovery","volume":"9","author":"Afkarian","year":"2010","journal-title":"Mol Cell Proteom"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.06.036_bib0490","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1099800411402056","article-title":"Searching for the noninvasive biomarker holy grail: are urine proteomics the answer?","volume":"13","author":"Voss","year":"2011","journal-title":"Biol Res Nurs"},{"issue":"9","key":"10.1016\/j.ejogrb.2017.06.036_bib0495","doi-asserted-by":"crossref","first-page":"e106488","DOI":"10.1371\/journal.pone.0106488","article-title":"Identification of protein biomarkers for cervical cancer using human cervicovaginal fluid","volume":"9","author":"Van Raemdonck","year":"2014","journal-title":"Plos One"},{"issue":"15","key":"10.1016\/j.ejogrb.2017.06.036_bib0500","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1016\/j.jprot.2012.05.018","article-title":"Detection and quantitation of forty eight cytokines, chemokines, growth factors and nine acute phase proteins in healthy human plasma, saliva and urine","volume":"75","author":"Khan","year":"2012","journal-title":"J Proteom"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517303135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517303135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:40:13Z","timestamp":1759556413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211517303135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":100,"alternative-id":["S0301211517303135"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.06.036","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-void urine: A potential biomarker source for triage of high-risk human papillomavirus infected women","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}